You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石药(01093.HK)终止与君实(01877.HK)之产品合作开发及战略合作协议
阿思达克 12-30 18:01

石药集团(01093.HK)公布,就治疗乳腺癌的联合用药之临床开发、注册及商业化订立战略合作协议一事,为了避免与集团另一抗PD-1单克隆抗体在研药物的临床研究及未来商业化可能引起的潜在冲突,经双方同意,公司与君实生物(01877.HK)於今年12月30日订立终止该协议的协议。

根据终止协议,订约双方同意,任何一方不得向另一方就公司已向君实支付的3,000万元人民币(下同)之里程碑款项及君实已向集团支付的368.39万元之临床研究费用提出任何申索。公司亦无责任向君实支付任何进一步里程碑款项。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account